N
Neukio Biotherapeutics
At a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 17.6/100
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jul 2021 | $40M | $160M | Sherpa Venture Partners · IDG Capital · Lilly Asia Ventures | — |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Neukio Biotherapeutics in its local ecosystem
The Neukio Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Sherpa Venture Partners
IDG Capital
Lilly Asia Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neukio Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neukio Biotherapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.